InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the detailed record of transactions filed by Anderson Cynthia Lynn. Director active across 1 company, notably VistaGen Therapeutics, Inc.. Cumulatively, 3 reports have been logged. History available since 28 June 2024. The latest transaction was filed on 30 June 2025 (Attribution). Regulator: SEC (Form 4). The full history is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 条申报中的 3 条